Molecular subgroup of primary prostate cancer presenting with metastatic biology.

<h4>Background</h4> <p>Approximately 4–25% of patients with early prostate cancer develop disease recurrence following radical prostatectomy.</p> <h4>Objective</h4> <p>To identify a molecular subgroup of prostate cancers with metastatic potential at present...

Full description

Bibliographic Details
Main Authors: Walker, SM, Knight, LA, McCavigan, AM, Logan, GE, Berge, V, Sherif, A, Pandha, H, Warren, AY, Davidson, C, Uprichard, A, Blayney, JK, Price, B, Jellema, GL, Steele, CJ, Svindland, A, McDade, SS, Eden, CG, Foster, C, Mills, IG, Neal, DE, Mason, MD, Kay, EW, Waugh, DJ, Harkin, DP, Watson, RW, Clarke, NW, Kennedy, RD
Format: Journal article
Language:English
Published: Elsevier 2017